EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immuno-persistence after the fourth and fifth doses of inactivated polio vaccines in school-aged children

Kathy Leung, Chrissy W K Pang, Tiffany H K Lo, Juan C Vargas-Zambrano, Céline Petit, Tommy T Y Lam, Eric H Y Lau, Joseph T Wu

Clinical Microbiology and Infection · 2025

DOI: 10.1016/j.cmi.2024.10.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2025. Verfasst von Kathy Leung und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Hong Kong Jockey Club Global Health Institute, Hong Kong Special Administrative Region, P. R. China; WHO Collaborating Centre for Infectious Dise…. Hauptthemen laut MEDLINE: Poliovirus Vaccine, Inactivated, Antibodies, Neutralizing, Antibodies, Viral, Poliomyelitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health and Medical Research Fund, Sanofi Pasteur SA, Bill and Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study aimed to assess the long-term persistence of neutralizing antibodies (nAb) titres and seroprotection proportions after the fourth and fifth doses of inactivated polio vaccine (IPV). METHODS: Serum samples from 299 children in Hong Kong were collected and used to estimate the persistence of nAb titres and seroprotection proportions by neutralisation test. RESULTS: The mean nAb titres against poliovirus types 1, 2, and 3 (PV1, PV2, and PV3) 1 month after receiving the fourth dose of IPV at 19 months of age were 2068 (95% credible interval, 1517-2864); 4705 (3439-6436); and 2758 (1894-4086); respectively, but declined substantially in 4 years to 268 (222-325), 751 (630-900), and 411 (323-521), respectively. Administration of the fifth dose of IPV restored nAb titres among children aged 6 to 7 years, and the decline in nAb titres was slightly slower with the estimated mean titres of 355 (272-462), 538 (427-681), and 548 (378-786) against PV1, PV2, and PV3 at 4 years post the fifth dose. We estimated that the proportion of children who were seroprotected against PV1, PV2, and PV3 would drop below 90%: (i) 8.2, 10.8, and 8.7 years after the fourth dose; and (ii) 11.6, 11.2, and 11.0 years after the fifth dose. DISCUSSION: The results revealed the immuno-persistence after the fourth and fifth doses of IPV and highlighted the importance of completing immunization series to ensure high vaccination coverage, particularly among children in the developing countries affected by the COVID-19 pandemic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poliovirus Vaccine, InactivatedAntibodies, NeutralizingAntibodies, ViralPoliomyelitisHumansChildMaleFemalePoliovirusHong KongChild, PreschoolInfantImmunization Schedule

Stichwörter der Autor:innen

IPVImmunopersistenceOPVPolioSerologyVaccine

Substanzen

Poliovirus Vaccine, InactivatedAntibodies, NeutralizingAntibodies, Viral

Autor:innen und Institutionen

  • The Hong Kong Jockey Club Global Health Institute, Hong Kong Special Administrative Region, P. R. China; WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Fac…
  • WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, P. R. China; Labo…
  • Laboratory of Data Discovery for Health Limited (D(2)4H), Hong Kong Science Park, Hong Kong Special Administrative Region, P. R. China.
  • Global Medical Affairs, Sanofi, Lyon, France.
  • Global Immunology, Sanofi, Marcy-l'Etoile, France.

Förderung

  • Health and Medical Research Fund
  • Sanofi Pasteur SA
  • Bill and Melinda Gates Foundation
  • Sanofi

Zitieren

APA

Leung, K., Pang, C. W. K., Lo, T. H. K., Vargas-Zambrano, J. C., Petit, C., Lam, T. T. Y., Lau, E. H. Y., & Wu, J. T. (2025). Immuno-persistence after the fourth and fifth doses of inactivated polio vaccines in school-aged children. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2024.10.007

Vancouver

Leung K, Pang CWK, Lo THK, Vargas-Zambrano JC, Petit C, Lam TTY, et al. Immuno-persistence after the fourth and fifth doses of inactivated polio vaccines in school-aged children. Clinical Microbiology and Infection. 2025. doi:10.1016/j.cmi.2024.10.007

BibTeX
@article{Leung2025,
  author = {Leung, Kathy and Pang, Chrissy W K and Lo, Tiffany H K and Vargas-Zambrano, Juan C and Petit, Céline and Lam, Tommy T Y and Lau, Eric H Y and Wu, Joseph T},
  title = {Immuno-persistence after the fourth and fifth doses of inactivated polio vaccines in school-aged children},
  journal = {Clinical Microbiology and Infection},
  year = {2025},
  doi = {10.1016/j.cmi.2024.10.007}
}
Kostenlos starten →